5 amino-1mq 10mg dosage 5-Amino-1MQ 5 AMINO 1MQ 10mg –

Route/evidence mismatch: the pivotal mouse study tested subcutaneous injection at a fixed research dose (20 mg/kg, three times daily) the oral capsule use that is actually sold and discussed commercially has not itself been directly tested in that published research

By reducing NNMT activity, the bodys ability to break down fat and generate cellular energy is restored

This educational protocol presents a subcutaneous injection approach to maximize bioavailability from the 50 mg vial format

The therapeutic window is 1025mg/mL for most research peptides, including 5-Amino-1MQ

Photographic Documentation Protocol Not required unless injection site reaction occurs